Views & Analysis AI diagnostics tools and oncology: predicting patient outcom... AI French-American biotech start-up Owkin recently published new research in
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
